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ndicator molecules for caspase-3 activation have been
reported that use ﬂuorescence resonance energy transfer
(FRET) between an enhanced cyan ﬂuorescent protein
(the donor) and enhanced yellow ﬂuorescent protein
(EYFP; the acceptor). Because EYFP is highly sensitive to
 
proton (H
 
 
 
) and chloride ion (Cl
 
 
 
) levels, which can
change during apoptosis, this indicator’s ability to trace the
precise dynamics of caspase activation is limited, especially
 
in vivo. Here, we generated an H
 
 
 
- and Cl
 
 
 
-insensitive
indicator for caspase activation, SCAT, in which EYFP was
replaced with Venus, and monitored the spatio-temporal
I
 
activation of caspases in living cells. Caspase-3 activation
was initiated ﬁrst in the cytosol and then in the nucleus,
and rapidly reached maximum activation in 10 min or less.
Furthermore, the nuclear activation of caspase-3 preceded
the nuclear apoptotic morphological changes. In contrast,
the completion of caspase-9 activation took much longer
and its activation was attenuated in the nucleus. However,
the time between the initiation of caspase-9 activation and
the morphological changes was quite similar to that seen for
caspase-3, indicating the activation of both caspases occurred
essentially simultaneously during the initiation of apoptosis.
 
Introduction
 
Programmed cell death, or apoptosis, is an essential event for
animal development and is observed in many developing tissues
in both invertebrates and vertebrates. The activation of the
caspase family is a central event in apoptosis. 14 members of
the caspase family have been reported in mammals (Shi, 2002);
seven in
 
 Drosophila melanogaster 
 
(Kumar and Doumanis,
2000), and three in 
 
Caenorhabditis elegans 
 
(Cryns and Yuan,
1998). All the caspases are synthesized in a precursor form
that requires processing for activation of the enzyme. Down-
stream caspases, such as caspase-3, are activated by upstream
caspases and then cleave many intracellular target proteins to
induce apoptotic cell death. Previous reports showed that
caspase-9– and caspase-3–null mutant mice exhibit reduced
apoptosis and morphological abnormalities in the developing
brain, including an expanded ventricular zone, ectopic neuronal
structures, and gross brain malformations (Kuida et al., 1996;
Hakem et al., 1998; Kuida et al., 1998). Knockout mice
lacking the caspase activator protein Apaf-1 also exhibit
reduced apoptosis in the embryonic brain and striking cranio-
facial abnormalities, with a hyperproliferation of neural cells
(Cecconi et al., 1998; Yoshida et al., 1998). These findings
strongly indicate that caspase activation is critical for normal
development, especially in the brain.
Fluorescence resonance energy transfer (FRET)* technology
can provide significant information about the dynamics and
 
pattern of endogenous caspase activation in vivo
 
.
 
 Several
papers have reported the use of recombinant caspase substrates
composed of enhanced cyan fluorescence protein (ECFP) as
the FRET donor and enhanced yellow fluorescence protein
(EYFP) as the FRET acceptor, linked by peptides containing
the caspase-3 cleavage sequence, DEVD (Tyas et al., 2000;
Luo et al., 2001; Rehm et al., 2002). The development of
such indicators has enabled researchers to monitor caspase
activation at the single-cell level in real time. However, these
 
The online version of this article includes supplemental material.
Address correspondence to Masayuki Miura, Laboratory for Cell Recovery
Mechanisms, RIKEN Brain Science Institute, 2-1 Hirosawa, Wako,
Saitama 351-0198, Japan. Tel.: 81-48-467-6945. Fax: 81-48-467-6946.
E-mail: miura@brain.riken.go.jp
Key words: FRET; caspase-3; caspase-9; nuclear activation of caspase-3;
apoptosis
 
*Abbreviations used in this paper:
 
 
 
Cl
 
 
 
, chloride ion; [Cl
 
 
 
]
 
i
 
, intracellular
 
Cl
 
 
 
 
 
concentration; CHX, cycloheximide; ECFP, enhanced cyan fluorescence
protein; EYFP, enhanced yellow fluorescent protein; FRET, fluorescence
resonance energy transfer; H
 
 
 
, proton; NLS, nuclear localization signal;
STS, staurosporine; TNF-
 
 
 
, tumor necrosis factor 
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indicators may have some limitations in the in vivo monitor-
ing of caspase activation for a number of reasons. First, the
molar extinction coefficient of the acceptor protein is an im-
portant factor for determining the efficiency of FRET; how-
ever, the molar extinction coefficient of EYFP is highly de-
pendent on the proton (H
 
 
 
) concentration, especially under
physiological pH conditions (pH 7.3; Llopis et al., 1998).
Second, EYFP is also highly sensitive to chloride ions (Cl
 
 
 
;
Jayaraman et al., 2000). In fact, owing to these characteris-
tics, EYFP has been used as an indicator for pH and Cl
 
 
 
;
EYFP-expressing transgenic mice are successfully used to de-
tect pH and Cl
 
 
 
 concentration changes in vivo (Metzger et
al., 2002). Thus, with changes in H
 
 
 
 or Cl
 
 
 
 concentrations,
indicators using EYFP as the FRET acceptor may detect sig-
nals that are not caused by caspase activity. Several reports
have suggested that acidification occurs during apoptosis
(Perez et al., 1995; Vincent et al., 1999; Matsuyama et al.,
2000) and that the Cl
 
 
 
/HCO
 
3
 
 
 
 antitransporter is involved
in apoptotic events (Maeno et al., 2000; Araki et al., 2002).
Because a change in Cl
 
 
 
 concentration is also known to be
associated with neuronal activity, it is crucial to use a Cl
 
 
 
 in-
sensitive indicator for monitoring caspases in neurons. A ra-
tiometric indicator (Clomeleon) in which CFP combined
with YFP via a flexible peptide linker, similar to the CY3
construct, was used as a reporter of intracellular Cl
 
 
 
 
 
concen-
tration ([Cl
 
 
 
]
 
i
 
) in cultured hippocampal neurons (Kuner
and Augustine, 2000). Using Clomeleon, changes in the so-
matic [Cl
 
 
 
]
 
i
 
 were observed to spread into dendrites after the
focal activation of GABA
 
A
 
 receptors on the soma of a neu-
ron. It would be hard to distinguish whether changes in the
ECFP/EYFP ratio were caused by [Cl
 
 
 
]
 
i
 
 changes or caspase
activation in neurons. For these reasons, EYFP-based acti-
vated caspase indicators must be improved for the reliable
monitoring of caspase activation in vivo.
Venus is a variant of EYFP that exhibits fast and efficient
maturation at 37
 
 
 
C (Nagai et al., 2002). The use of Venus as
an acceptor for FRET in the Ca
 
2
 
 
 
 indicator (YC2.12) allows
the Ca
 
2
 
 
 
 signal to be detected immediately after the gene is
introduce into cells. Furthermore, the absorption efficiency of
Venus is significantly less sensitive to H
 
 
 
 and Cl
 
 
 
 than that of
EYFP. Therefore, Venus should be a more suitable FRET ac-
ceptor than EYFP in indicators for activated caspase. In this
paper, we report an improved indicator for caspase activation
based on the FRET method (SCAT) that uses Venus in place
of EYFP. We clearly show that SCAT is highly resistant to
changes in H
 
 
 
 and Cl
 
 
 
 concentration in vitro and insensitive
to environmental effects in living cells, allowing us to detect
reliable signals for caspase activation. We also show the spa-
tio-temporal dynamics of caspase-3 (DEVDase) activation in
the cytosol and nuclei using SCAT3. Finally, by monitoring
caspase-9 (LEHDase) in living HeLa cells using SCAT9, we
report for the first time a difference in the spatio-temporal dy-
namics between initiator and executioner caspases.
 
Results
 
Improved indicator for activated caspase: SCAT
 
We generated a hybrid protein, ECFP-Venus, with an 18-
amino acid linkage. The linking sequences contained an op-
timum sequence for caspase cleavage, which was used in a
 
previous report (Tyas et al., 2000). Caspase activity is de-
tected from the FRET from ECFP to Venus; thus, cleavage
of the linker peptide by activated caspases abolishes the
FRET (Fig. 1 A). We named this indicator SCAT (a sensor
for activated caspases based on FRET). We constructed two
SCATs, SCAT3 and SCAT9, which contained the DEVD
(SCAT3) or LEHD (SCAT9) sequence in the linker region,
which is mainly cleaved by caspase-3 or caspase-9, respec-
tively (Thornberry et al., 1997; Fig. 1 B). We constructed
SCAT3 (DEVG) for control experiments; it contained a gly-
cine substituted for a critical aspartic acid as the fourth resi-
due of the cleavage site. To detect the nuclear activation of
caspase-3, we also constructed nuclear localization signal
(NLS)-SCAT3.
To confirm the FRET in the SCAT protein, SCAT3
was expressed in HeLa cells, which were then treated with
tumor necrosis factor-
 
 
 
/cycloheximide (TNF-
 
 
 
/CHX),
Figure 1. An improved indicator for activated caspases: SCAT. 
(A) Schematic representation of SCAT. (B) Linker sequences of the 
SCAT family of indicators. (C) Spectral analysis of SCAT3 in cells 
exposed to TNF- /CHX. HeLa cells in 100-mm dishes were trans-
fected with 6  g pcDNA-SCAT3. 18 h after transfection, the cells 
were exposed to CHX or TNF- /CHX and incubated for 6 h. The cell 
suspensions were then subjected to spectral analysis. (D) Changes in 
the emission ratio (530/475 nm) of SCAT3 compared with CY3 in 
cells treated with TNF- /CHX. The cell suspensions were prepared 
as described above. The 530/475-nm emission ratio was measured 
with an excitation wavelength at 435 nm. The data represent results 
from three independent experiments. Error bars indicate SD.T
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and the emission spectra of the cell suspensions were mea-
sured (Fig. 1 C). Before TNF-
 
 
 
/CHX treatment, bimodal
emission peaks at 475 and 530 nm were observed with ex-
citation at 435 nm. After 6 h of exposure to TNF-
 
 
 
/
CHX, which strongly activates caspase-3, the emission
peak at 530 nm disappeared and the peak at 475 nm rose,
suggesting the cleavage of the linker. To confirm that the
emission peak at 530 nm was caused by FRET, the accep-
tor Venus was photobleached by strong excitation at 525
nm, which does not bleach ECFP. As expected, the emis-
sion peak at 475 nm was dequenched, indicating that
there was FRET between ECFP and Venus in SCAT (un-
published data).
The value for the 530/475 nm emission ratio of SCAT3
changed from 2.29 to 0.90 in response to TNF-
 
 
 
/CHX treat-
ment, whereas the ratio for CY3 changed from 1.86 to 0.68
(Fig. 1 D). The wider dynamic range of the FRET signal
from SCAT3 (1.40 
 
 
 
 0.08; 
 
n
 
 
 
 
 
 3) compared with that from
CY3 (1.18 
 
 
 
 0.05; 
 
n
 
 
 
 
 
 3) may be explained by the complete
maturation of Venus, the acceptor contained in SCAT3.
 
SCAT is resistant to pH and Cl
 
 
 
 
 
concentration changes
 
Our initial goal was to generate an indicator for caspase acti-
vation under physiological conditions, such as in a develop-
ing embryo. It is important that the indicator does not de-
tect any signals except for caspase activation. We noticed
that CY3 was significantly sensitive to changes in the con-
centration of both H
 
 
 
 and Cl
 
 
 
 (Fig. 2, A and B) in vitro.
For example, acidification from pH 7.5 to 7.0 decreased the
emission ratio of CY3 by 26%. Under the same conditions,
only a 0.01% decrease was observed for SCAT3. Therefore,
SCAT3 was highly stable under these conditions compared
with CY3.
To examine these effects in living cells, we monitored the
FRET of SCAT3 or CY3 in HeLa cells treated with an
apoptosis inducer, staurosporine (STS). A decrease in
FRET was observed in SCAT3 and CY3 in response to STS
treatment (Fig. 2 C), and these substrate cleavages were
confirmed by Western blotting (Fig. 2 E). The caspase
cleavage site mutant, SCAT3 (DEVG), did not show any
FRET changes until the cells had completely adopted the
Figure 2. Properties of SCAT3 and CY3. pH 
resistance (A) and Cl
  resistance (B) of SCAT3 
compared with CY3. HeLa cells transfected with 
pcDNA-SCAT3 or pCFP-DEVD-YFP were lysed 
with 0.5% Triton X-100–containing buffer. The 
530/475-nm emission ratio was determined with 
a 435-nm excitation wavelength. The data represent 
results from three independent experiments. Error 
bars indicate SD. (C and D) The stability of SCAT 
compared with CY3 in living single cells. The 
imaging analysis was started on exposing HeLa 
cells to 1  M STS at 18 h after transfection. To 
compare SCAT3 and CY3, the emission ratio was 
normalized by defining the baseline ratio before 
the FRET disruption as 1. Arrowheads indicate the 
time cells first showed the early apoptotic cell 
death morphology, including membrane blebbing 
and cell shrinkage. (E) Western blot analysis of 
SCAT3- or CY3-expressing HeLa cells exposed by 
STS. (F) The emission intensity profiles of EYFP and 
ECFP in CY3 (DEVG)-expressing HeLa cells. Cells 
1 and 2 are the same as those shown in D. Arrows 
indicate the time of the emission ratio decrease in 
CY3 (DEVG) in D.T
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apoptotic morphology. However, all of the CY3 (DEVG)-
expressing HeLa cells showed a significant decrease in
FRET (15.1 
 
 
 
 4.4%, compared with the decrease seen
with CY3, 
 
n
 
 
 
 
 
 21; Fig. 2 D) without CY3 (DEVG) cleav-
age in the presence of STS (Fig. 2 E). The decrease in the
emission ratio of CY3 (DEVG) was caused by a decrease in
the emission intensity of EYFP and an increase in the emis-
sion intensity of ECFP (Fig. 2 F). Only a small percentage
of the SCAT (DEVG)-expressing cells showed a decrease in
signal like the one seen with CY3 (DEVG; 2 of 16 cells ex-
amined), but the decrease in FRET of SCAT (DEVG) was
less than that of CY3 (DEVG; 4.5 and 3.3%, respectively).
SCAT becomes sensitive to pH to some extent if the pH is
below 6.5, and it is possible that this kind of severe change
may occur in a small percentage of cells. Together, these re-
sults indicate that SCAT can detect the activation of
caspases more specifically than CY3.
 
Specificity of SCAT3 for activated caspase-3 
in apoptotic HeLa cell extract
 
Next, we examined the specificity of SCAT3 for activated
caspases in vitro. In vitro
 
-
 
synthesized SCAT3 protein was
incubated with several activated caspases (Fig. 3 A). It was
efficiently cleaved by caspase-3 and partially cleaved by
caspase-8 and caspase-9 in vitro. In contrast, little SCAT3
was cleaved by caspase-6. To investigate the specificity of
SCAT3 in the TNF treated cell lysates, we performed
immunodepletion experiments to remove caspase-3 from
TNF-
 
 
 
/CHX-treated HeLa cell lysates. Caspase-3 activation
was observed at TNF-
 
 
 
/CHX-treated lysates (Fig. 3 B),
then caspase-3 precursor and its activated form were de-
pleted from apoptotic lysates by an anti-caspase-3 antibody.
As a control, we incubated TNF-
 
 
 
/CHX-treated lysates
with an anti-GFP antibody. We then examined SCAT3
cleavage in these extracts. SCAT3 was effectively cleaved in
the control TNF-
 
 
 
/CHX-treated lysates (whether or not
they had been treated with the GFP antibody). On the other
hand, only a small portion of the SCAT3 was cleaved in the
caspase-3–depleted lysates. These results indicated that most
of the SCAT3 cleavage in TNF-
 
 
 
/CHX-treated HeLa cell
lysates was done by caspase-3.
 
Real-time imaging of the dynamics and patterning of 
caspase-3 activation in living HeLa cells 
 
Using SCAT3, we monitored the activation of caspase-3
(DEVDase) in living HeLa cells after TNF-
 
 
 
/CHX expo-
sure. The cleavage of SCAT3, but not of SCAT3 (DEVG),
after TNF-
 
 
 
/CHX treatment was observed by Western blot
analysis (Fig. 4 A), and we could not detect a significant ra-
tio change in the SCAT3 (DEVG) FRET in response to
TNF-
 
 
 
/CHX (unpublished data). We found that once cas-
pase-3 activation was initiated in the cytosol, it progressed
very rapidly, reaching its maximum in 7.2 
 
 
 
 1.8 min (
 
n
 
 
 
 
 
13; Fig. 4, B and C, and Video 1, available at http://
www.jcb.org/cgi/content/full/jcb.200207111/DC1). These
imaging analyses also enabled us to observe the activation of
caspase-3 in the nucleus (see next paragraph).
 
Nuclear activation of caspase-3 precedes the apoptotic 
nuclear morphological change 
 
We constructed and expressed NLS-SCAT3, in which an
NLS was placed at the COOH terminus (Fig. 5 A). We
monitored the nuclear morphology by phase-contrast images
at the same time. We observed that in the presence of TNF-
 
 
 
/CHX, caspase-3 was activated in the nucleus. Interestingly,
the simultaneous observation of morphology and fluores-
cence revealed that the nuclear activation of caspase-3 pre-
ceded the apoptotic nuclear morphological changes, such as
nuclear fragmentation. In addition, we observed the leakage
of NLS-SCAT3 protein from the nucleus into the cytosol
when the nuclear morphological changes had been com-
pleted (Fig. 5 A). We also found that, as observed in the cyto-
sol, the nuclear activation of caspase-3 was a rapid process,
reaching its maximum in 11.6 
 
 
 
 3.7 min (
 
n
 
 
 
 
 
 17; Fig. 5 B).
 
Specificity of SCAT9 for caspase-9 
in apoptotic HeLa cell extract
 
The caspase-9–mediated mitochondrial pathway is critical
for the physiological apoptosis that occurs in normal devel-
opment (Cecconi et al., 1998; Hakem et al., 1998; Kuida et
al., 1998; Yoshida et al., 1998). To examine the caspase-9
activation by real-time imaging analysis, we constructed
SCAT9, which contains a caspase-9 cleavage-site sequence,
LEHD, in its linker region. To test whether SCAT9 could
be cleaved specifically by caspase-9, the SCAT9 protein was
generated in vitro and incubated with recombinant activated
caspase-3, caspase-6, caspase-8, and caspase-9. SCAT9 was
cleaved by caspase-8 and caspase-9 with the same efficiency
but not by caspase-3 or caspase-6 (Fig. 6 A). We then first
examined SCAT9 specificity in TNF-
 
 
 
/CHX-treated HeLa
cell lysate. Because of the weak enzymatic activities of
caspase-9 in apoptotic extracts from TNF-
 
 
 
/CHX-treated
HeLa cells, only the small amount of SCAT9 cleavage was
observed in this lysate. In stead, we examined its specificity
Figure 3. The specificity of SCAT3 for activated caspase-3 in 
TNF- /CHX-treated HeLa cell lysates. (A) In vitro cleavage analysis 
of SCAT3. SCAT3 synthesized in vitro was incubated with 1 U of 
purified activated caspase-3, -6, -8, or -9 for 1 h. The reaction 
mixture was subjected to Western blotting using an anti-myc mAb. 
(B) Immunodepletion of caspase-3 from TNF- /CHX-treated HeLa 
cell lysates. 20  g of immunodepleted lysates were subjected to 
Western blotting using an anti–caspase-3 rabbit pAb (Invitrogen). 
(C) Cleavage assay of SCAT3 in caspase-3–depleted lysates. SCAT3 
synthesized in vitro was incubated with 12  g caspase-3–depleted 
lysates prepared from TNF- /CHX-treated HeLa cells for the indicated 
periods, and then its cleavage was examined by Western blotting 
using an anti-myc antibody.T
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in apoptotic HeLa extract induced by cytochrome 
 
c
 
 and
dATP. Most of pro- and activated caspase-9 was immunode-
pleted from apoptotic lysate (Fig. 6 B), and SCAT9 cleavage
was examined using caspase-9 depleted lysate. SCAT9 was
cleaved in the apoptotic lysates but its cleavage was signifi-
cantly but not completely blocked by the immunodepletion
of caspase-9 (Fig. 6 C). Because we could detect a small
amount of caspase-9 in the caspase-9–depleted lysates, it is
possible that residual caspase-9 cleaved the SCAT9 in the
caspase-9–depleted apoptotic lysate. However, we cannot
exclude the possibility that other caspases were involved in
this cleavage.
 
Real-time imaging analysis of caspase-9 using SCAT9 
 
SCAT9 was cleaved in HeLa cells after exposure to TNF-
 
 
 
/
CHX (Fig. 7 A). Therefore, we used SCAT9 to monitor the
caspase-9 activation in living HeLa cells (Fig. 7 B and Video
2). Activation was observed in the cytosol, but it was unclear
in the nuclei. In contrast to the caspase-3 activation by
TNF-
 
 
 
/CHX, the activation of caspase-9 was a very slow
process that took at least 48 min (
 
n   13) to reach its maxi-
mum (see Fig. 7 C, where it took 77.5 min and 91.5 min in
cell 1 and cell 2, respectively). However, the time from the
initial caspase-9 activation to the formation of apoptotic
morphological changes was 10.1   2.1 min (n   13), which
was similar to the time course seen with caspase-3 (10.0  
2.1 min; n   13). Therefore, these results indicate that the
initiation of the caspase-3 and caspase-9 activation occurred
at almost the same time, but caspase-3 and caspase-9 activa-
tion was completed before and after the apoptotic morpho-
logical changes, respectively (Fig. 7 D).
Discussion 
In this work, we developed an improved activated caspase
monitoring protein named SCAT. By using Venus as a
FRET acceptor, we made SCAT highly resistant to acidifica-
tion and high Cl
  concentration, as assessed by in vitro ti-
tration assays. SCAT is thus an ideal indicator for reliably
detecting FRET signals that are associated with caspase
activation. During animal development, apoptosis is de-
tected in specific regions of the morphogenesis. For exam-
ple, many cells undergoing apoptosis are observed in the
hindbrain roof plate during neural tube closure (Weil et al.,
1997), and limb buds are shaped by the apoptotic cell death
of the interdigital cells (Zou and Niswander, 1996). These
apoptotic cell deaths are likely to be specifically patterned
and are associated with normal development. Therefore, cas-
pases must play a critical role in development through their
involvement in apoptosis. The generation of transgenic ani-
mals expressing SCAT will enable us to investigate the spa-
tio-temporal activation of the caspases in developmental
apoptosis in vivo. Because SCAT is insensitive to changes in
Cl
  and H
 , it is especially useful for monitoring caspase ac-
tivation in neurons. Recently, apoptosis-independent (but
activity-dependent) caspase activation was reported in pri-
Figure 4. Single-cell imaging analysis of SCAT3-
expressing living HeLa cells. (A) Western blot 
analysis of SCAT3-expressing HeLa cells exposed 
to TNF- /CHX. HeLa cells in a 6-well plate were 
transfected with 1  g pcDNA-SCAT3. Cells were 
exposed to 50 ng/ml TNF-  and 10  g/ml CHX 18 h 
after transfection. The cells were then lysed with 
sample buffer at the indicated times. The lysates 
were examined by Western blotting using an anti-
myc antibody. (B) Ratio images of the SCAT3-
expressing cells. HeLa cells were transfected with 
0.5  g pcDNA-SCAT3. Imaging analysis was started 
18 h after transfection. (C) Venus/ECFP emission 
ratio changes of individual cells examined in B. 
Arrowheads indicate the time cells first showed the 
early apoptotic cell death morphology, including 
membrane blebbing and cell shrinkage.T
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mary cortical neurons (Meyer et al., 2002). SCAT will also
provide an indispensable tool to elucidate the physiological
roles and activation mechanisms of caspases independent of
apoptosis in neurons. In this report, the use of NLS-SCAT
permitted us to show that the nuclear activation of caspase-3
preceded the observation of apoptotic nuclear morphologi-
cal changes. The precursor form of caspase-3 is predomi-
nantly synthesized in the cytosol (Chandler et al., 1998;
Mancini et al., 1998; Zhivotovsky et al., 1999; Faleiro and
Lazebnik, 2000). Together, our data and these reports indi-
cate that activated caspase-3 can be translocated from the cy-
tosol into the nucleus. Although many caspase-3 substrates
have been reported, the significance of the nuclear activation
of caspase-3 has not yet been studied. ICAD and CAD com-
plex, which is responsible for the apoptotic nuclear fragmen-
tation, also reside in the nucleus in nonapoptotic cells. (Le-
chardeur et al., 2000). It might be possible that CAD is
activated by cleavage of ICAD in nucleus. Nuclear lamins
are intermediate filament proteins that are major compo-
nents of the nuclear lamina and are cleaved by caspase-6,
downstream of caspase-3 (Ruchaud et al., 1997). A previous
report suggested that the expression of uncleavable mutant
lamin A or B caused significant delays in the onset of chro-
matin condensation and nuclear shrinkage during apoptosis.
In addition, apoptotic DNA fragmentation was delayed in
these cells (Rao et al., 1996). Therefore, the nuclear activa-
tion of caspase-3 may induce the early nuclear morphologi-
cal changes during apoptosis.
We showed another application of SCAT by creating
SCAT9, which contained LEHD in its linker sequence. The
specificity of this indicator for caspase-9 was examined by an
in vitro cleavage assay and immunodepletion assay using
dATP/cytochrome c–activated apoptotic HeLa cell lysates.
The in vitro cleavage assay revealed that SCAT9 was cleaved
not only by caspase-9, but also by caspase-8. If caspase-8 is
strongly activated in cells, SCAT9 should detect the activa-
tion of caspase-8 as well. In apoptotic HeLa cell lysates,
SCAT9 cleavage was significantly suppressed by the deple-
Figure 5. Nuclear activation of 
caspase-3 precedes apoptotic nuclear 
changes. (A) Ratio images and phase-
contrast images of NLS-SCAT–expressing 
cells. HeLa cells were transfected with 
0.5  g pcDNA-SCAT3. Imaging analysis 
was started 18 h after transfection. 
(B) Venus/ECFP emission ratio changes 
of individual cells examined in A.
Figure 6. Specificity of SCAT9 for activated caspase-9 in apoptotic 
HeLa cell extract. (A) In vitro cleavage analysis of SCAT9. SCAT9 
synthesized in vitro was cleaved by purified activated caspase-3, 
-6, -8, or -9 for 1 h. The reaction mixture was then subjected to 
Western blotting using an anti-myc mAb. (B) Immunodepletion of 
caspase-9 from dATP/cytochrome c activated apoptotic HeLa extract. 
Immunodepleted extracts (18  g) were subjected to Western 
blotting using an anti-caspase-9 mouse mAb. Both the precursor 
and activated forms of caspase-9 could be depleted from the extracts. 
(C) Cleavage assay of SCAT9 in caspase-9–depleted apoptotic 
extracts. SCAT9 synthesized in vitro was incubated with 18  g 
caspase-9–depleted apoptotic extracts for the indicated periods. 
The reacted lysates were then examined by Western blotting using 
an anti-myc antibody.T
h
e
 
J
o
u
r
n
a
l
 
o
f
 
C
e
l
l
 
B
i
o
l
o
g
y
 Spatio-temporal activation of caspases | Takemoto et al. 241
tion of caspase-9, indicating that SCAT9 is mainly cleaved
by caspase-9 in these samples. Because we could detect par-
tial cleavage of SCAT9 in the caspase-9–depleted apoptotic
lysates, the possible involvement of other caspases cannot be
excluded. Another possibility is that residual caspase-9 in the
lysates is involved in the cleavage of SCAT9 after caspase-9
immunodepletion. Because caspase-9 is incorporated into
the apoptosome, which is a large protein complex, it might
prevent the access of the caspase-9 antibody to completely
deplete the caspase-9 from the apoptotic lysates.
The caspase-9 activation profile was significantly different
from that of caspase-3. The changes in the emission ratio of
SCAT9 occurred very slowly compared with the changes in
that of SCAT3. Caspase-3 activation was completed before
the initiation of apoptotic morphological changes, but cas-
pase-9 activation continued to progress after the morpholog-
ical changes. These different rates of caspase-3 and caspase-9
activation may be caused by differences in their potential
protease activity. When we measured the enzymatic activity
of caspase-9 (LEHDase activity) and caspase-3 (DEVDase)
in TNF- /CHX-stimulated HeLa cells, the DEVDase activ-
ity was six times higher than that of LEHDase. Caspase-9
would thus take longer to complete the cleavage of SCAT9
than caspase-3 takes to cleave SCAT3 if there are similar lev-
els of the SCAT substrates in cells. In spite of the differences
in activation profiles between caspase-3 and -9, the timing of
the initiation of these caspases was almost the same (Fig. 7
D). Thus, we provide the first and direct evidence that acti-
vation of the initiator caspase and the executioner caspase is
temporally coupled to initiate apoptotic changes.
Materials and methods
Gene construction
To construct SCAT3 and SCAT3 (DEVG), Venus was amplified using the fol-
lowing primers: forward, 5’-TTTGGGGTACCAGCGGAAGCGAATTCGT-
GAGCAAGGGCGAGGAG-3’; reverse, 5’-TTTCGCTCGAGAAGCTTGCG-
GCCGCTTACTTGTACAGCTCGTCCAT-3’. The resulting PCR product was
digested with KpnI-HindIII, gel-purified, and ligated into the KpnI-HindIII site
of the pCFP-DEVD-YFP vector or pCFP-DEVG-YFP, provided by Dr. Jeremy
M. Tavare (University of Bristol, Bristol, UK; Tyas et al., 2000) to generate
pcDNA-SCAT3 and pcDNA-SCAT3 (DEVG), respectively. NLS-SCAT3 was
generated by adding the nuclear localization signal PKKKRKVEDA to the
COOH terminus of SCAT3. To construct SCAT9, ECFP was amplified using
the following primers: forward, 5’-TCGACGGATCCGACGAGATGGAGCA-
GAAGCTGATCTCGGAGGAGGACCTGAAGGTGAGCAAGGGCGAGG-3’;
reverse, 5’-TTTGCGGTACCGTCGTGCTCGAGTCCGCTGAGCTCGGACG-
AGGACTTGTACAGCTCGTCCAT-3’. The PCR products were then digested
with BamHI-KpnI, gel-purified, and ligated into the BamHI-KpnI site of
pcDNA-SCAT3 to generate pcDNA-SCAT9.
Cell culture and transfection
HeLa cells were maintained in DME (Sigma-Aldrich) supplemented with
100 U/ml penicillin, 100  g/ml streptomycin, and 10% FBS. Transfections
of HeLa cells were performed using the SuperFect reagent (QIAGEN).
Spectral analysis
SCAT3-expressing HeLa cells were exposed to 10  g/ml CHX or 50 ng/ml
TNF- /10  g/ml CHX for 6 h, then washed three times in PBS at 37 C. The
Figure 7. Single-cell imaging analysis of caspase-9 
activation using SCAT9. (A) Western blot analysis 
of SCAT9-expressing HeLa cells treated with 
TNF- /CHX. HeLa cells cultured in a 6-well plate 
were transfected with 1  g pcDNA-SCAT9. The 
cells were treated with 50 ng/ml TNF-  and 10  g/
ml CHX 18 h after the transfection. The cells were 
then lysed with sample buffer at the indicated times. 
The lysates were examined by Western blotting 
using an anti-myc antibody. (B) Ratio images of the 
SCAT9-expressing HeLa cells exposed to 50 ng/ml 
TNF-  and 10  g/ml CHX. HeLa cells were trans-
fected with 0.5  g pcDNA-SCAT9. Imaging analy-
sis was started 18 h after transfection. (C) Venus/
ECFP emission ratio changes of individual cells 
examined in B. Arrowheads indicate the time cells 
first showed early apoptotic cell death morphological 
changes, such as membrane blebbing and cell shrink-
age. (D) Schematic representation of the activation 
profile of caspase-3 (DEVDase) and -9 (LEHDase). 
Arrows indicate the time point of each event.T
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cells were resuspended in PBS and used for fluorescence spectra determi-
nations with an excitation wavelength of 435 nm at 37 C using a fluores-
cence spectrophotometer (model F2500; Hitachi).
pH and Cl
  titration analysis
For pH titration, a series of buffers was prepared with pHs ranging from 6
to 9 in either 50 mM 2-(N-morpholino) ethanesulfonate, Hepes, or Tris, in
the presence of 0.5% Triton X-100, 100 mM KCl, and protease inhibitors
(5  g/ml pepstatin, 10  g/ml leupeptin, 2  g/ml aprotinin, 0.1 mM PMSF).
For Cl
  titration, a series of buffers was prepared with Cl
  concentrations
ranging from 0 to 450 mM in 0.5% Triton X-100 containing 50 mM Hepes-
KOH, pH 7.4, 5  g/ml pepstatin, 10  g/ml leupeptin, 2  g/ml aprotinin,
and 0.1 mM PMSF. The ionic strength of these solutions was adjusted to
450 mM with potassium D-gluconate.
HeLa cells (2   10
5 cells) were plated on 6-well plates and harvested at
18 h. The cells were transfected with 1  g pSCAT3 or pCFP-DEVD-YFP
(CY3). 24 h after transfection, SCAT3- or CY3-expressing HeLa cells were
washed with PBS (37 C) and incubated in the indicated solutions at 37 C
for 10 min. The supernatant, obtained by centrifugation at 10,000 g for 10
min at 37 C, was subjected to measurement of the 530/475-nm emission
ratio with an excitation wavelength of 435 nm at 37 C.
Western blotting
Cell lysates were prepared by washing cells in PBS, then resuspending the
cell pellet in sample buffer (62.5 mM Tris-HCl, pH 6.8, 6 M urea, 10%
glycerol, 2% SDS, 0.003% bromophenol blue, and 5% mercaptoethanol).
The sample was immediately incubated for 10 min at 95 C, and the cell
debris was pelleted before loading the sample onto an SDS-polyacryl-
amide gel (12%). After electrophoresis, the proteins were transferred onto
an Immobilon™ membrane (Millipore) in transfer buffer (25 mM Tris, 192
mM glycine, and 20% methanol). An anti-myc mouse mAb (Invitrogen)
and HRP-conjugated anti–mouse IgG (Promega) were used to detect full-
length and cleaved SCAT.
Imaging analysis
Cells were plated on polyethyleneimine-coated glass coverslips and trans-
fected with 0.5  g plasmid vector for 6 h, then maintained in growth me-
dium for another 12 h. During imaging, the cells were maintained in HBSS
(GIBCO BRL) containing 10 mM Hepes, pH 7.4, and placed in a heated
chamber. Imaging analysis was carried out using illumination pillars
(ILL100LH; Olympus) with an interlined charge-coupled device camera
(CoolSNAP HQ™; Roper Scientific) controlled by MetaFluor 4.6.5 Soft-
ware (Universal Imaging Corp.). A 440AF21 excitation filter, a 455DRLP
dichroic mirror, and two emission filters (480AF30 for ECFP and 535AF25
for Venus or EYFP) were used for SCAT or CY3 imaging. The two emission
filters alternated with a filter changer (Lambda 10-2; Sutter Instrument Co.).
In vitro cleavage of SCAT3 and SCAT9
The in vitro cleavage assay was performed as described previously (Na-
kanishi et al., 2001). The SCAT3 or SCAT9 protein was prepared by in vitro
translation and transcription using a TNT-coupled reticulocyte lysate sys-
tem (Promega). 2  l SCAT3 or SCAT9 protein was incubated at 37 C with
1 U purified, active caspase-3, -6, -8, or -9 (MBL International Corpora-
tion) for 1 h. The reaction mixture contained 20 mM Hepes-KOH (pH 7.5),
10 mM KCl, 1.5 mM MgCl2, 1 mM EDTA, 1 mM EGTA, 1 mM dithiothrei-
tol, 19  g/ml aprotinin, and 0.1 mM PMSF. Western blot analysis with the
anti-Myc antibody was used to detect the proteins, as described above.
Preparation of apoptotic extracts for SCAT3 and SCAT9 
cleavage assay
For SCAT3 cleavage assay, HeLa cells were treated with 50 ng/ml TNF- 
and 10  g/ml CHX and then cultured for 6 h. After washes by PBS two
times, cells were suspended by digitonin buffer (10  M digitonin, 50  M
Tris-HCl, pH 7.5, 1 mM EDTA, and 10 mM EGTA). Samples were incu-
bated at 37 C for 10 min and then centrifuged at 15,000 rpm. The superna-
tant was collected and MgCl2 was added at final concentration of 2 mM.
For SCAT9 cleavage assay, HeLa cells were harvested by centrifugation
at 1,000 rpm for 5 min. After washes in PBS and Buffer A (20 mM Hepes-
KOH, pH 7.5, 10 mM KCl, 1.5 mM MgCl2, 1 mM EDTA, 1 mM EGTA, 1
mM DTT, 0.1 mM PMSF, 5  g/ml pepstatin A, 10  g/ml leupeptin, and 2
 g/ml aprotinin), the cells were suspended in two vol of buffer A and incu-
bated 20 min on ice. The cells were then homogenized by 15 strokes with a
Dounce homogenizer using a B-type pestle. The lysates were clarified by
centrifugation at 10,000 g for 1 h. The supernatant was collected, and NaCl
was added to a final concentration of 50 mM. The in vitro apoptotic reac-
tion was carried out by the addition of 10  M cytochrome c and 1 mM
dATP for 2 h at 37 C in 3  g/ l lysate before immunodepletion experiment.
Immunodepletion of caspase-3 or caspase-9 
from apoptotic extracts
Aliquots of protein G Sepharose (40  l) were precoated with 5  g anti-cas-
pase-9 rabbit pAb, provided by Drs. Yutaka Eguchi and Yoshihide Tsuji-
moto (Osaka University, Osaka, Japan; Eguchi et al., 1999), 5  g anti-cas-
pase-3 mouse mAb (Transduction Laboratories), or 5  g anti-GFP rabbit
pAb (MBL International Corporation) in a total volume of 300  l in Buffer
A, and were rocked for 3 h at 4 C. Antibody-coated beads were washed
three times with Buffer A, then mixed with apoptotic HeLa cell lysates (150
 g of cytochrome c/dATP apoptotic lysate for SCAT9 and 100  g of TNF-
 /CHX-treated apoptotic lysate for SCAT3 as described above) and rocked
for 3 h at 4 C. The beads were removed from the lysates before SCAT3 or
SCAT9 cleavage assay.
Online supplemental materials
Videos 1 and 2 show real-time imaging analyses of apoptotic HeLa cells
using the SCAT3 and SCAT9 indicators, respectively. HeLa cells were
treated with 50 ng/ml TNF-  and 10  g/ml CHX. Changes in the emis-
sion ratio are represented as red (high ratio) to blue (low ratio). Online
supplemental material available at http://www.jcb.org/cgi/content/full/
jcb.200207111/DC1.
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